[go: up one dir, main page]

LT3536B - A slimming pharmaceutical composition - Google Patents

A slimming pharmaceutical composition Download PDF

Info

Publication number
LT3536B
LT3536B LTIP702A LTIP702A LT3536B LT 3536 B LT3536 B LT 3536B LT IP702 A LTIP702 A LT IP702A LT IP702 A LTIP702 A LT IP702A LT 3536 B LT3536 B LT 3536B
Authority
LT
Lithuania
Prior art keywords
ephedrine
caffeine
agonist
treatment
less
Prior art date
Application number
LTIP702A
Other languages
English (en)
Lithuanian (lt)
Inventor
Arne Astrup
Original Assignee
Dak Lab As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dak Lab As filed Critical Dak Lab As
Publication of LTIP702A publication Critical patent/LTIP702A/xx
Publication of LT3536B publication Critical patent/LT3536B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTIP702A 1989-07-07 1993-06-23 A slimming pharmaceutical composition LT3536B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK339289A DK339289D0 (da) 1989-07-07 1989-07-07 Farmaceutisk praeparat

Publications (2)

Publication Number Publication Date
LTIP702A LTIP702A (en) 1995-01-31
LT3536B true LT3536B (en) 1995-11-27

Family

ID=8122369

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP702A LT3536B (en) 1989-07-07 1993-06-23 A slimming pharmaceutical composition

Country Status (18)

Country Link
US (1) US5422352A (fr)
EP (1) EP0480934B1 (fr)
JP (1) JP2584899B2 (fr)
KR (1) KR0159045B1 (fr)
AT (1) ATE107858T1 (fr)
AU (1) AU638992B2 (fr)
CA (1) CA2063598C (fr)
DE (1) DE69010336T2 (fr)
DK (2) DK339289D0 (fr)
ES (1) ES2055911T3 (fr)
FI (1) FI920026A7 (fr)
HU (1) HU220071B (fr)
LT (1) LT3536B (fr)
LV (1) LV10192B (fr)
NO (1) NO920051L (fr)
RU (1) RU2109511C1 (fr)
UA (1) UA27779C2 (fr)
WO (1) WO1991000730A1 (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5865869A (en) * 1991-08-02 1999-02-02 Ecologel Usa, Inc. Solution for plant root watering
WO1994000432A1 (fr) * 1992-06-30 1994-01-06 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Derives d'epinephrine anorexiques
JPH08509203A (ja) * 1992-10-15 1996-10-01 ダナ−ファーバー キャンサー インステテュート インコーポレイテッド ＴＮＦ−α作用の拮抗剤を用いる肥満関連糖尿病▲ＩＩ▼型のインスリン耐性の治療
ES2094687B1 (es) * 1994-08-02 1997-12-16 S A L V A T Lab Sa Combinacion farmaceutica contra la obesidad o el sobrepeso.
FR2746644A1 (fr) * 1996-03-18 1997-10-03 Firion Jackie Produit parapharmaceutique moderateur d'appetit
ATE453385T1 (de) * 1996-09-30 2010-01-15 Dennis Jones Regulation von körpergewicht durch materialien basierend auf zitrusvariationen
US6224873B1 (en) 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
EP0946155B2 (fr) 1996-12-23 2009-01-21 S.L.A. Pharma AG Composition pharmaceutique destinee au traitement de l'incontinence fecale
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
WO2000000184A2 (fr) * 1998-06-26 2000-01-06 Delack Elaine A Traitement de la sclerose en plaques
US7232830B2 (en) 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
US6340482B1 (en) 2000-05-18 2002-01-22 Zhishin, Llc Methods for inducing weight loss in a human with materials derived from Citrus varieties
US6113949A (en) * 1998-10-27 2000-09-05 Prolab Nutrition, Inc. Weight control product and method of treating hyperlipidemia and increasing vigor with said product
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
FR2788438B1 (fr) * 1999-01-14 2003-10-03 Arkopharma Laboratoires Composition pour le traitement de l'obesite et procede de traitement esthetique
US6576272B1 (en) * 1999-03-05 2003-06-10 Twin Laboratories Incorporated Dietary supplement and method of using same
WO2001005356A2 (fr) * 1999-07-20 2001-01-25 Natrol, Inc. Produit de surveillance de poids a base d'un melange synergique d'extrait de guggul, de sel de phosphate et un stimulant metabolique
CA2382666A1 (fr) * 1999-08-23 2001-03-01 The Administrators Of The Tulane Educational Fund Modulation de transporteur de leptine a travers la barriere hemato-encephalique
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
DE10011541A1 (de) * 2000-03-06 2001-09-20 Reimann Hartmut Verwendung einer Kombination aus Ephedrin und Coffein und/oder Theophyllin zur Vitalisierung von Knochenfischen, Wasserzusatz zur Vitalisierung von Knochenfischen
US6316499B1 (en) 2000-05-18 2001-11-13 Zhishin, Llc Methods for increasing the muscle mass of a human with materials derived from citrus varieties
US20030054015A1 (en) * 2000-12-25 2003-03-20 Shinichiro Haze Sympathetic-activating perfume composition
US7048941B2 (en) * 2001-03-30 2006-05-23 New World Enterprizes, Inc. Chocolate composition as delivery system for nutrients and medications
US7041305B2 (en) * 2001-09-07 2006-05-09 Western Holdings, Llc Stable water in oil aminophylline emulsions
RU2209582C2 (ru) * 2001-10-22 2003-08-10 Горелик Самуил Лейбович Способ контроля веса пациента
GB0130763D0 (en) 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
AU2003224507A1 (en) * 2002-04-19 2003-11-03 N.V. Nutricia Multiphasic diet
US8142810B2 (en) * 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
US20040224031A1 (en) * 2003-05-06 2004-11-11 Antonio Zorzano Olarte Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus
EP2250911A1 (fr) 2003-10-17 2010-11-17 Diet Formulations Ltd. Supplement amaigrissant
AU2004292416B2 (en) * 2003-11-20 2010-01-28 Alteragon Pty Ltd Method of decreasing fat deposits and body weight in mammals and birds
PL209905B1 (pl) * 2004-01-15 2011-11-30 Bringwell Internat Ab Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego
CA2455248A1 (fr) * 2004-01-29 2005-07-29 Alexander Zolotoy Administration par voie orale de r-albuterol pour lutter contre l'obesite
US7524064B2 (en) * 2004-03-09 2009-04-28 Research Foundation Of The State University Of New York Apparatus and method for assessing retinal damage
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20060134230A1 (en) * 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US20060204599A1 (en) * 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US9610429B2 (en) * 2010-12-29 2017-04-04 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with targeted substance delivery
IN2015DN03188A (fr) 2012-10-08 2015-10-02 Rivalea Australia Pty Ltd
US9877434B2 (en) 2013-05-30 2018-01-30 Ecologel Solutions, Llc Granular compositions and methods for drought mitigation
CA2943385C (fr) * 2014-03-26 2022-06-21 Rivalea (Australia) Pty Ltd Methode destinee a ameliorer l'efficience alimentaire chez des ruminants
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
HK1246601A1 (zh) 2015-02-13 2018-09-14 马斯公司 宠物食物饲喂系统
WO2016167855A1 (fr) * 2015-04-14 2016-10-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Association d'albutérol et de caféine pour le traitement synergique de l'obésité ou de la sarcopénie
GB201522296D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat
WO2020232424A1 (fr) 2019-05-16 2020-11-19 Nexus Pharmaceuticals, Inc. Compositions comprenant de l'éphédrine ou un sel d'éphédrine et leurs procédés de fabrication et d'utilisation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2004183B (en) 1977-06-03 1982-03-03 Pharma Export Promotion Counci Slimming composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390164A1 (fr) * 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5011843A (en) * 1988-05-31 1991-04-30 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2004183B (en) 1977-06-03 1982-03-03 Pharma Export Promotion Counci Slimming composition

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
A.V. ASTRUP: "Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathicomimetic stimulation", ACTA ENDOCRINOL. SUPPL., 1986, pages 1 - 32
A.V. ASTRUP: "Treatment of obesity with thermogenic agents.", NUTRITION, 1989, pages 70
CESARI MP: "The therapeutic dilemma of ephedrine in obesity and the inefficacy of caffeine", INT J OBES REL METAB DISORD, 1989, pages 152
DULLOO AG, MILLER DS.: "Ephedrine, caffeine and aspirin: "over-the-counter" drugs that interact to stimulate thermogenesis in the obese.", NUTRITION, 1989, pages 7 - 9
DULLOO AG, MILLER DS.: "The thermogenic properties of ephedrine/methylxanthine mixtures: human studies", INT J OBES, 1986, pages 467 - 481
J. R. S. ARCH ET AL.: "Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs", NATURE, 1984, pages 163 - 165, XP000942079, DOI: doi:10.1038/309163a0
M. A. HOLLANDS, J. R. ARCH, .M .A CAWTHORNE: "A simple apparatus for comparative measurements of energy expenditure in human subjects: the thermic effect of caffeine", AM J CLIN NUTR, 1981, pages 2291 - 2294
NO AUTHORS LISTED: "Treatment of obesity in adults. Council on Scientific Affairs.", JAMA, 1988, pages 2547 - 2548
P. D. WARRISS, S. C. KESTIN, T. P. ROLPH, S.: "The effects of the beta-adrenergic agonist salbutamol on meat quality in pigs", JOURNAL OF ANIMAL SCIENCE, 1990, pages 128 - 136
P. E. V. WILLIAMS: "The Use of .beta. Agonists As a Means of Altering Body Composition in Livestock Species", NUTRITION ABSTRACTS AND REVIEWS (SERIES B), 1987, pages 453 - 464
P. J. BUTTERY, J. H. DAWSON: "Elsevier Applied Science", pages: 29 - 44
SEBOK M.: "A double-blinded, placebo-controlled, clinical study of the efficacy of a phenylpropanolamine/caffeine combination product as an aid to weight loss in adults", CURR THER RES, 1984, pages 701 - 708

Also Published As

Publication number Publication date
LTIP702A (en) 1995-01-31
DE69010336D1 (de) 1994-08-04
CA2063598A1 (fr) 1991-01-08
ATE107858T1 (de) 1994-07-15
HK1001821A1 (en) 1998-07-10
HUT62798A (en) 1993-06-28
DK0480934T3 (da) 1994-11-07
AU5630890A (en) 1991-02-06
KR0159045B1 (ko) 1998-12-01
JPH04507091A (ja) 1992-12-10
UA27779C2 (uk) 2000-10-16
DK339289D0 (da) 1989-07-07
WO1991000730A1 (fr) 1991-01-24
LV10192A (lv) 1994-10-20
EP0480934B1 (fr) 1994-06-29
HU9200051D0 (en) 1992-06-29
AU638992B2 (en) 1993-07-15
FI920026A0 (fi) 1992-01-03
US5422352A (en) 1995-06-06
CA2063598C (fr) 1997-12-09
RU2109511C1 (ru) 1998-04-27
EP0480934A1 (fr) 1992-04-22
JP2584899B2 (ja) 1997-02-26
DE69010336T2 (de) 1994-11-03
FI920026A7 (fi) 1992-01-03
HU220071B (hu) 2001-10-28
NO920051L (no) 1992-01-31
NO920051D0 (no) 1992-01-03
ES2055911T3 (es) 1994-09-01
LV10192B (en) 1995-06-20

Similar Documents

Publication Publication Date Title
LT3536B (en) A slimming pharmaceutical composition
Earnest et al. High-performance capillary electrophoresis-pure creatine monohydrate reduces blood lipids in men and women
Haller et al. Short‐term metabolic and hemodynamic effects of ephedra and guarana combinations
CA2039194C (fr) Utilisations de l-deprenyl et de compositions qui en derivent
EP3043789B1 (fr) Utilisation des agonistes de ppar-delta pour le traitement de l'atrophie musculaire
JP2002526379A (ja) インシュリン活性を増強する組成物およびその方法
US20070088078A1 (en) Methods for managing adipocyte fat accumulation
Ewell et al. Edible marijuana and cycle ergometer exercise
WO2007019526A2 (fr) Compositions et procedes pour controler l'apport de glucose et de lipide par des aliments
Clayton et al. Phase I randomized placebo-controlled, double-blind study of the safety and tolerability of bremelanotide coadministered with ethanol in healthy male and female participants
Jenner et al. Cyclosporin A treatment of young children with newly-diagnosed Type 1 (insulin-dependent) diabetes mellitus
Sanayei et al. Chlorella vulgaris in combination with high intensity interval training in overweight and obese women: a randomized double-blind clinical trial
EP3574912B1 (fr) Composition pour traiter une maladie diabétique
Bulum et al. Madelung’s disease: case report and review of the literature
US20160346340A1 (en) Compositions including milk thistle and methods for the treatment of various disorders using the same
US20180055848A1 (en) Combination of Albuterol and Caffeine as Synergistic Treatment for Obesity or Sarcopenia
Liu et al. Intermittent fasting increases growth differentiation factor 15 in females with overweight or obesity but not associated with food intake
Mayasari The analysis of the use a combination of metformin and glibenclamide drugs with blood glucose levels at diabetes mellitus patients
HK1001821B (en) A slimming pharmaceutical composition
Cunha et al. Nutritonal evaluation of pemphigus foliaceus patients on long term glucocorticoid therapy
Green et al. Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol.
Safamanesh et al. Cytotoxic Effect and Insulin-Like Characteristic of Peganum harmala: An in vitro Study
Arthur et al. Fecal short chain fatty acids predict eating behavior of postmenopausal women after completion of a dietary pulses intervention
KR20030071974A (ko) 비만억제 및 치료를 위한 약제약적 조성물
CN109700964B (zh) 一种减肥的组合物及其制备方法与用途

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20060623